P&U Launches UK Management Center

12 February 1996

Newly-formed Swedish-American drugmaker Pharmacia & Upjohn Inc launched its new management center and corporate logo in London on February 5, just 90 days after the completion of the merger (Marketletters passim). The center will be located in Windsor (also home of the Queen of England at Windsor Castle), just 10 miles or so west of London's Heathrow airport.

The location was chosen because London is "recognized as the world's financial and air transportation center....and a natural hub for a worldwide enterprise," according to P&U president and chief executive John Zabriskie, who will be based in Windsor. The new logo is shown below.

As well as the centralized steering and decision-making unit, P&U will have three pharma product centers responsible for various therapeutic activities: Kalamazoo, USA, for central nervous system, neurology, critical care, infectious diseases, inflammation and women's health products; Stockholm, Sweden, will take care of metabolic diseases, nutrition, ophthalmology, plasma, thrombosis and urology; and Milan will handle the oncology area. The structuring is expected to provide the strength of a major drugmaker - P&U now ranks ninth in worldwide turnover - plus the flexibility of three smaller companies, Dr Zabriskie told journalists.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight